A Randomized, Phase II, Multicenter, Open Label, Study Evaluating Sirolimus and Prednisone in Patients with Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease (GMT CTN Protocol 1501
Clinical Trial Grant
Awarded By
National Marrow Donor Program
Start Date
October 15, 2016
End Date
October 14, 2021
Awarded By
National Marrow Donor Program
Start Date
October 15, 2016
End Date
October 14, 2021